September 2026
The global terbinafine hydrochloride drug market size was evaluated at USD 1.59 billion in 2026 and is predicted to hit around USD 3.43 billion by 2035, growing at a CAGR of 8.92%.
September 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
September 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
September 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
September 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.49 billion in 2026 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
September 2026
The uterine fibroid drugs market reached USD 3.61 billion in 2026, featuring leading uterine fibroid drugs market companies such as AbbVie Inc., Pfizer Inc., Bayer AG, Takeda Pharmaceutical Company Limited.
September 2026
The contraceptive drugs and devices market size reached USD 35.23 billion in 2026 and is projected to surpass around USD 58.87 billion by 2035, with a notable CAGR of 5.88%.
September 2026
The articaine hydrochloride market was valued at USD 1.74 billion in 2026, with leading companies including Septodont, Pierrel S.p.A, Dentsply Sirona.
September 2026
The global anthelmintic drugs market size was evaluated at USD 4.4 billion in 2026 and is predicted to hit around USD 9.01 billion by 2035, growing at a CAGR of 8.30%.
September 2026
The global performance enhancing drugs market size was evaluated at USD 468.43 million in 2026 and is predicted to hit around USD 892.09 million by 2035, growing at a CAGR of 7.42%.
September 2026
The global general anesthesia drugs market size was calculated at USD 5.81 billion in 2026 and is projected to surpass around USD 8.06 billion by 2035, with a CAGR of 3.71%.
September 2026
The global critical care drugs market size was evaluated at USD 1.28 billion in 2026 and is projected to surge around USD 2.00 billion by 2035, with a CAGR of 5.07%.
September 2026
The global expectorant drugs market size was evaluated at USD 19.56 billion in 2026 and is predicted to hit around USD 29.72 billion by 2035, growing at a CAGR of 4.76%.
September 2026
The global antitussive drugs market size was evaluated at USD 1.81 billion in 2026 and is predicted to hit around USD 2.86 billion by 2035, growing at a CAGR of 5.23%.
September 2026
The global PD-1 inhibitor drugs market size was estimated at USD 56.29 billion in 2026 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
September 2026
The injectable drug delivery market reached USD 829.98 billion in 2026, with prominent companies such as Sandoz, therumo, schott ag, gerresheimer, ypsormed leading the injectable drug delivery market.
September 2026
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 7.62 billion in 2026 with a solid CAGR of 9.90%.
September 2026
The advanced drug delivery market size is calculated at USD 103.84 billion in 2026 and is projected to hit around USD 371.83 billion by 2035 with a CAGR of 15.26%.
September 2026
The global erectile dysfunction drugs market size was estimated at USD 2.93 billion in 2024 and is predicted to be worth around USD 6.74 billion by 2034, with a CAGR of 8.69%.
September 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 23.13 billion in 2026, with a CAGR of 14.63%.
September 2026
The global fixed-dose combination diabetes drugs market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The liver cancer drug market was valued at USD 5.19 billion in 2026, with leading companies including Bayer AG, Bristol Myers Squibb.
September 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.17 billion in 2026 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
September 2026
The global pingueculum drugs market size was evaluated at USD 891.64 million in 2026 and is predicted to hit around USD 1,660.04 million by 2035, growing at a CAGR of 7.15%.
September 2026
The global sedative-hypnotic drugs market size was evaluated at USD 16.80 billion in 2026 and is predicted to hit around USD 31.94 billion by 2035, growing at a CAGR of 7.40%.
September 2026
The global antiepileptic drugs market size was evaluated at USD 19.02 billion in 2026 and is predicted to hit around USD 30.80 billion by 2035, growing at a CAGR of 5.50%.
September 2026
The global synthetic lethality-based drugs and targets market size was evaluated at USD 2.19 billion in 2026 and is predicted to hit around USD 9.37 billion by 2035, growing at a CAGR of 17.52%.
September 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
September 2026
The contraceptive drugs market size reached USD 20.12 billion in 2026, with leading contraceptive drugs market companies including Pfizer Inc., Bayer AG, Merck and Co. Inc.
September 2026
The rheumatoid arthritis drugs market size reached USD 65.51 billion in 2026, with leading rheumatoid arthritis drugs market companies including AbbVie Inc., Sun Pharma, Lupin.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com